MetaCap

REGENXBIO (RGNX) News

NASDAQ: RGNXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

7.16-0.02 (-0.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

RGNX news summary

We found 7 recent headlines mentioning REGENXBIO (RGNX): 0 in the past week and 6 in the past 30 days, most often from PR Newswire, Nasdaq, Seeking Alpha. For price context, RGNX is down 0.28% at $7.16. The most recent story, "Regenxbio outlines RGX-202 full BLA filing in Q1 2027 with cash runway late into Q4 2027", was published by Seeking Alpha on Nov 5, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest REGENXBIO headlines

Stocks mentioned alongside RGNX

Compare RGNX